ECMO管理中の凝固評価-Reference-Cited by-同舟云学术

ECMO管理中の凝固評価

Published:2023-02-01 Issue:1 Volume:39 Page:46-48
ISSN:0911-1794
Container-title:Pediatric Cardiology and Cardiac Surgery
language:en
Short-container-title:Ped Cardiol Card Surg

Author:

Ebishima Hironori¹

Affiliation:

1. Intensive Care Unit, National Center for Child Health and Development

Publisher

The Japanese Society of Pediatric Cardiology and Cardiac Surgery

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jspccs/39/1/39_EC2022-0028/_pdf

Reference17 articles.

1. 1) Extracorporeal Life Support Organization (ELSO): Adult and Pediatric Anticoagulation Guidelines. [cited 2021 May 10]. Available from: https://www.elso.org/ecmoresources/elso-ecmo-guidelines.aspx

2. 2) Avendaño A, Ferguson JJ: Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 23: 907–910

3. 3) Despotis GJ, Summerfield AL, Joist JH, et al: Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994; 108: 1076–1082

4. 4) Gui YY, Huang FY, Huang BT, et al: The effect of activated clotting time values for patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Thromb Res 2016; 144: 202–209

5. 5) Mottillo S, Filion KB, Joseph L, et al: Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression. Catheter Cardiovasc Interv 2017; 89: 351–366